Atrion Corp
NASDAQ:ATRI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Asuransi Bina Dana Arta Tbk PT
IDX:ABDA
|
ID |
|
S
|
Semapa Sociedade de Investimento e Gestao SGPS SA
ELI:SEM
|
PT |
|
C
|
Curanex Pharmaceuticals Inc
NASDAQ:CURX
|
US |
|
O
|
Obm Drilchem Tbk PT
IDX:OBMD
|
ID |
|
Channel Infrastructure NZ Ltd
NZX:CHI
|
NZ |
|
Gatekeeper Systems Inc
XTSX:GSI
|
CA |
|
Lam Research Corp
NASDAQ:LRCX
|
US |
|
Interface Inc
NASDAQ:TILE
|
US |
|
D
|
Distoken Acquisition Corp
NASDAQ:DIST
|
CN |
Atrion Corp
Gross Profit
Atrion Corp
Gross Profit Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Atrion Corp
NASDAQ:ATRI
|
Gross Profit
$58.3m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-1%
|
|
|
Haemonetics Corp
NYSE:HAE
|
Gross Profit
$782m
|
CAGR 3-Years
10%
|
CAGR 5-Years
13%
|
CAGR 10-Years
6%
|
|
|
ICU Medical Inc
NASDAQ:ICUI
|
Gross Profit
$822m
|
CAGR 3-Years
6%
|
CAGR 5-Years
12%
|
CAGR 10-Years
16%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Gross Profit
$2.8B
|
CAGR 3-Years
2%
|
CAGR 5-Years
9%
|
CAGR 10-Years
16%
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Gross Profit
$942m
|
CAGR 3-Years
17%
|
CAGR 5-Years
45%
|
CAGR 10-Years
21%
|
|
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
Gross Profit
$738.3m
|
CAGR 3-Years
12%
|
CAGR 5-Years
13%
|
CAGR 10-Years
12%
|
|
Atrion Corp
Glance View
Atrion Corp. engages in the manufacture and development of products for medical applications. The company is headquartered in Allen, Texas and currently employs 667 full-time employees. The firm's medical products primarily serve the fluid delivery, cardiovascular and ophthalmology markets. The company has developed a variety of valves designed to fill, hold and release controlled amounts of fluids or gasses on demand for use in various intubation, intravenous, catheter and other applications in fields, such as anesthesia and oncology. The firm's cardiovascular product, Myocardial Protection System (MPS3), is a technology used in open-heart surgery that delivers fluids and medications, mixes critical drugs, and controls temperature and pressure. Its ophthalmic products include specialized medical devices that disinfect contact lenses. The company also manufactures a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults. Its medical and non-medical products are manufactured at facilities in Florida, Alabama and Texas.
See Also
What is Atrion Corp's Gross Profit?
Gross Profit
58.3m
USD
Based on the financial report for Jun 30, 2024, Atrion Corp's Gross Profit amounts to 58.3m USD.
What is Atrion Corp's Gross Profit growth rate?
Gross Profit CAGR 10Y
-1%
Over the last year, the Gross Profit growth was -15%. The average annual Gross Profit growth rates for Atrion Corp have been -3% over the past three years , -4% over the past five years , and -1% over the past ten years .
